Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Completed · Phase 2

Conditions studied: Cervical Cancer, Precancerous Condition

In brief

RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.

Key facts

Study ID

NCT00031759

Run by

Alliance for Clinical Trials in Oncology

People needed

57

Starts

1999-06-01

Expected to finish

2010-02-01

Last updated by the study team

2016-07-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• CCOP - Mayo Clinic Scottsdale Oncology Program — Scottsdale, Arizona, United States
• Mayo Clinic — Jacksonville, Florida, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• CCOP - Wichita — Wichita, Kansas, United States
• CCOP - Michigan Cancer Research Consortium — Ann Arbor, Michigan, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.